These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32209279)

  • 21. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A; Aldemir DA; Bayrak T; Corakçi A; Dursun P
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of two hormone replacement therapy regimens, oral oestradiol valerate and cyproterone acetate versus transdermal oestradiol and oral dydrogesterone, on lipid metabolism.
    Schram JH; Boerrigter PJ; The TY
    Maturitas; 1995 Sep; 22(2):121-30. PubMed ID: 8538480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid profile changes during the menopausal transition.
    Inaraja V; Thuissard I; Andreu-Vazquez C; Jodar E
    Menopause; 2020 Jul; 27(7):780-787. PubMed ID: 32187130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins: Prespecified Secondary End Points in ORION 1.
    Ray KK; Stoekenbroek RM; Kallend D; Leiter LA; Landmesser U; Wright RS; Wijngaard P; Kastelein JJP
    Circulation; 2018 Sep; 138(13):1304-1316. PubMed ID: 29735484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Menopausal stages and serum lipid and lipoprotein abnormalities in middle-aged women.
    Choi Y; Chang Y; Kim BK; Kang D; Kwon MJ; Kim CW; Jeong C; Ahn Y; Park HY; Ryu S; Cho J
    Maturitas; 2015 Apr; 80(4):399-405. PubMed ID: 25631350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone replacement therapy and lipid-lipoprotein concentrations.
    Gökmen O; Yapar Eyi EG
    Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):31-41. PubMed ID: 10428319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of menopause and obesity on lipid profiles in middle-aged Taiwanese women: the Chin-Shan Community Cardiovascular Cohort Study.
    Torng PL; Su TC; Sung FC; Chien KL; Huang SC; Chow SN; Lee YT
    Atherosclerosis; 2000 Dec; 153(2):413-21. PubMed ID: 11164431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simvastatin, transdermal patch, and oral estrogen-progestogen preparation in early-postmenopausal hypercholesterolemic women: a randomized, placebo-controlled clinical trial.
    Vigna GB; Donegà P; Zanca R; Barban A; Passaro A; Pansini F; Bonaccorsi G; Mollica G; Fellin R
    Metabolism; 2002 Nov; 51(11):1463-70. PubMed ID: 12404199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of dyslipidemia and associated risk factors among Turkish adults: Trabzon lipid study.
    Erem C; Hacihasanoglu A; Deger O; Kocak M; Topbas M
    Endocrine; 2008; 34(1-3):36-51. PubMed ID: 19003544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction.
    Tenenbaum A; Fisman EZ
    Cardiovasc Diabetol; 2012 Oct; 11():125. PubMed ID: 23057687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial.
    Casanova G; Spritzer PM
    Lipids Health Dis; 2012 Oct; 11():133. PubMed ID: 23046709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimum lipid testing for diabetic patients to enhance clinical care.
    Devaraj S; Jialal I
    Diabetes Metab Syndr; 2021; 15(1):461-464. PubMed ID: 33607521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of the normalization of TSH and free T4 on lipid profile in a pediatric population with primary hypothyroidism.
    Rivera-Hernández A; Rojas-Martínez R; Mendoza-Zubieta V; Balcázar-Hernández L
    Andes Pediatr; 2021 Feb; 92(1):59-66. PubMed ID: 34106184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suboptimal lipid levels in clinical practice among Portuguese adults with dyslipidemia under lipid-lowering therapy: Data from the DISGEN-LIPID study.
    da Silva PM; Aguiar C; Morais J;
    Rev Port Cardiol (Engl Ed); 2019 Aug; 38(8):559-569. PubMed ID: 31706732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Parameters of lipid metabolism in postmenopausal women on oral or transdermal hormone replacement with or without progesterone].
    Foth D; Römer T; Benthin A
    Zentralbl Gynakol; 2000; 122(9):483-8. PubMed ID: 11050765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-fasting lipid profile determination in presumably healthy children: Impact on the assessment of lipid abnormalities.
    Szternel L; Krintus M; Bergmann K; Derezinski T; Sypniewska G
    PLoS One; 2018; 13(6):e0198433. PubMed ID: 29927973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis.
    Rees M; Angioli R; Coleman RL; Glasspool R; Plotti F; Simoncini T; Terranova C
    Maturitas; 2020 Apr; 134():56-61. PubMed ID: 32059825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.